肥胖与黑人血液中的B型尿素度的关系:杰克逊心脏研究
Ervin R Fox1, Solomon K Musani, Aurelian Bidulescu
1University of Mississippi Medical Center, Division of Cardiovascular Diseases, 2500 N State St, Jackson, MS 39216, USA. efox@medicine.umsmed.edu
Circulation
|August 10, 2011
概括
在黑人成年人中,较高的体重指数与较低的B型性尿素 (BNP) 水平有关,这表明"性尿素障碍"可能会导致这个人群中与肥胖相关的高血压.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 与肥胖相关的高血压是一个越来越令人担忧的问题.
- 在肥胖个体中,较低的B型尿素度 (BNP),称为"尿障碍",可能会导致高血压.
- 这种现象在黑人群体中的作用仍然不清楚.
研究的目的:
- 调查黑人成年人体质指数 (BMI) 和血BNP度之间的关系.
- 为了测试BMI与该人口中的BNP水平相反的假设.
主要方法:
- 在没有心力衰竭的杰克逊心脏研究中对3742名参与者的横截面研究.
- 使用多变量线性和逻辑回归分析,根据临床和心声学因素进行调整.
- 进行了特定性别的分析,以检查男性和女性之间的差异.
主要成果:
- 较高的BMI与正常血压和高血压的黑人个体中较低的多变量调整平均BNP度有关.
- 这种反向关系在男性和女性中都被观察到,在正常压力参与者中差异更为明显.
- BNP水平与连续和分类BMI指标都有显著的相关性.
结论:
- 较高的BMI与较低的循环BNP度有关,在一个大型的,基于社区的黑人成年人样本中.
- 这一发现扩大了"天然尿障碍"的概念,包括肥胖的黑人,这是高风险患高血压的人群.
- 结果表明,在黑人人口中,肥胖与高血压之间存在潜在的联系机制.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
